Genetics and epigenetics

It could be possible to predict Alzheimer’s risk using virtual reality navigational testing, decades before symptoms develop

Sitting Down With David Klimstra, Chair, Department of Pathology; James Ewing Alumni Chair of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Molecular techniques can offer rapid, accurate diagnosis of lung infections in cystic fibrosis, but most labs feel the technologies are out of reach. What if there was an affordable alternative?

Gene expression panel could help breast cancer patients with a low risk of recurrence avoid unnecessary chemotherapy

A genetic test for prostate cancer risk could be used in screening, and improve the diagnostic value of PSA

Tumor-activated DNA minicircles offer a potential solution for cancer detection, treatment, or both.

A new approach aims to answer the urgent need for genomic pathology education

There’s a whole new world of molecular diagnostics out there. Why has innovation been restricted?

Virology remains a rapidly changing field and the diagnostic clinical laboratory must keep abreast of newer viruses, targets and technologies

RNA biomarkers lag behind DNA and proteins in clinical use because of the limitations of lab technology – but new analytical tools could now make RNA a useful tool in the pathologist’s kit